Prognosis and NT-proBNP decrease in heart failure patients from admission to follow up

29 August 2025 (07:00 - 18:00)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Ms Paula Rodriguez Montes

University Hospital Getafe, Madrid (Spain)

8 More presentations in this session

Presentation thumbnail

Discussant - Diagnosis of heart failure: natriuretic peptides and novel methods

Presentation thumbnail

Clinical correlates and outcomes associated with B-type natriuretic peptide changes and their interaction with eplerenone in acute heart failure: findings from the EARLEIR trial

Doctor A. Tezuka (Tokyo, JP)

Presentation thumbnail

The prognostic implications of serum NT-pro B-type Natriuretic Peptide (NT-proBNP) in emergency medical admissions.

Doctor M. Mckittrick (Limerick, IE)

Abstract Slides Video

Presentation thumbnail

Artificial intelligence-assisted point-of-care lung ultrasound to compare B-lines and congestion scores with NTproBNP levels prior to discharge patients with acute heart failure stage C

Doctor C. Neerapattanakul (Bangkok, TH)

Abstract Slides

Presentation thumbnail

The responses of B-type natriuretic peptide (BNP), mature BNP, proBNP, atrial natriuretic peptide, and N-terminal proBNP to sacubitril/valsartan differs between responders and non-responders

Doctor T. Nishikimi (Osaka, JP)

Abstract Slides Video

Access the full session

Session thumbnail

New perspectives in cardiology (2) - Diagnosis of heart failure: natriuretic peptides and novel methods

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025

You may be interested in

Congress Session

Biomarkers to guide the treatment of heart failure: where are we going?

Congress Session

Biomarkers definning pathophysiology and prognosis

Congress Session

Late breaking clinical trials: drugs and devices

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources